long term risks of glp 1 Application nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions Long-Term GLP-1 Safety: GI Risks

L.KellerS

At the biochemical level, NPs mainly affect the production and metabolism of glucose, triglycerides and fatty acids, while at the transcriptional level, NPs primarily affect production of rate-limiting enzymes of glycolipid metabolism, leading to disorders of glycolipid metabolism

The supplier and publisher of this document assume no liability for misuse, abuse, or unauthorized application of the information or material provided

[PMC free article: PMC6766977] [PubMed: 30828788] 213

Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform

10.3390/ijerph8093764